Apple Wins FDA Approval for Watch-Based Hypertension Detection
Apple has received FDA approval for its new hypertension detection feature on the Apple Watch, introduced at its September event alongside the iPhone Air and iPhone 17 lineup. This feature uses advanced machine learning to analyze data from the watch's optical heart sensor over 30 days, alerting users to potential chronic hypertension. Apple aims to enhance digital health solutions amid competition from Garmin and Samsung. AAPL stock holds a Moderate Buy consensus rating, with a price target of $240.63, indicating a potential 4.6% upside, despite a 7.8% year-to-date decline.
The hypertension detection system was first introduced at its recent annual September event, where the company also unveiled its thinnest iPhone to date, the iPhone Air, along with the iPhone 17 lineup and new AirPods.
Why the Hypertension Feature Matters
The new hypertension feature was built using advanced machine learning (ML) and data from studies involving over 100,000 participants. Apple stated that the tool will analyze data from the Apple Watch's optical heart sensor to track how a user's blood vessels respond to heartbeats over a 30-day period. If it detects signs of chronic hypertension, or high blood pressure, the watch will alert the user and recommend sharing the results with a healthcare provider.
Apple continues to expand its footprint in digital health amid growing competition from tech companies such as Garmin Ltd. (GRMN) and Samsung Electronics (SSNLF). Hypertension is a critical global health issue, affecting an estimated 1.3 billion adults worldwide and increasing the risk of heart attack, stroke, and kidney disease. High blood pressure can usually be managed through lifestyle changes or medication. However, Apple wants to help users spot health problems early using everyday technology.
Is AAPL Stock a Buy, Hold, or Sell?
On TipRanks, AAPL stock has a Moderate Buy consensus rating based on 14 Buys, 15 Holds, and two Sell ratings. The average Apple price target of $240.63 implies 4.6% upside potential from current levels. Year-to-date, AAPL stock has lost 7.8%.
